Abstract:We have reported that epoxyeicosatrienoic acids (EETs), the cytochrome P450 (CYP) epoxygenase metabolites of arachidonic acid (AA), are potent sarcolemmal ATP-sensitive K+ (K-ATP) channel activators. However, activation of cardiac and vascular K-ATP channels by endogenously produced EETs under physiological intracellular conditions has not been demonstrated and direct comparison of the mechanisms whereby EETs activate the K-ATP channels in cardiac myocytes versus vascular smooth muscle cells has not been made. In this study, we examined the effects of AA on K-ATP channels in freshly isolated cardiac myocytes from rats, wild-type (WT) and transgenic mice overexpressing CYP2J2 cDNA, and mesenteric arterial smooth muscle cells from rats. We also compared the activation of cardiac and vascular K-ATP channels by extracellularly and intracellularly applied 11,12-EET. We found that 1 mu m AA enhanced K-ATP channel activities in both cardiac and vascular smooth muscle cells, and the AA effects were inhibited by preincubation with CYP epoxygenase inhibitors. Baseline cardiac K-ATP current densities in CYP2J2 transgenic mice were 190% higher than those of WT mice, and both were reduced to similar levels by CYP epoxygenase inhibition. Western blot analysis showed that expression of Kir6.2 and SUR2A was similar between WT and CYP2J2 transgenic hearts. 11,12-EET (5 mu m) applied intracellularly enhanced the K-ATP currents by 850% in cardiac myocytes, but had no effect in vascular smooth muscle cells. In contrast, 11,12-EET (5 mu m) applied extracellularly increased K-ATP currents by 520% in mesenteric arterial smooth muscle cells, but by only 209% in cardiac myocytes. Preincubation with 100 mu m m-iodobenzylguanidine or 5 mu m myristoylated PKI amide did not alter the activation of cardiac K-ATP channels by 5 mu m 11,12-EET, but significantly inhibited activation of vascular K-ATP channels. Moreover, EET only enhanced the inward component of cardiac K-ATP currents, but activated both the inward and outward components of vascular K-ATP currents. Our results indicate that endogenously derived CYP metabolites of AA potently activate cardiac and vascular K-ATP channels. EETs regulate cardiac electrophysiology and vascular tone by K-ATP channel activation, albeit through different mechanisms: the cardiac K-ATP channels are directly activated by EETs, whereas activation of the vascular K-ATP channels by EETs is protein kinase A dependent.

The cyclooxygenase-2 product prostaglandin E2 modulates cardiac contractile function in adult rat ventricular cardiomyocytes

[Involvement of Nitric Oxide in the Effect of Interleukin-2 on the Contractility of Rat Ventricular Cardiomyocytes].

Prostaglandin-E2 Contracts Vascular Smooth-Muscle and Inhibits Potassium Currents in Vascular Smooth-Muscle Cells of Rat Tail Artery

Prostaglandin E2 affects mitochondrial function in adult mouse cardiomyocytes and hearts

Modulation of Interleukin- 2 on the Positive Effect of Isoproterenol in the Isolated Cardiomyocytes

Abstract Mo139: PDE1, 3 and 4 Inhibition and GPCR Agonism in the Regulation of cAMP Signaling

Cardiac and Vascular K-Atp Channels in Rats Are Activated by Endogenous Epoxyeicosatrienoic Acids Through Different Mechanisms

PGE2 protects against heart failure through inhibiting TGF-β1 synthesis in cardiomyocytes and crosstalk between TGF-β1 and GRK2

Cardiac and vascular K ATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms: Activation of cardiac and vascular K ATP channels by EETs

Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility

Prostaglandin E2 Induced Cardiac Hypertrophy Through EP2 Receptor‐dependent Activation of Β‐catenin in 5/6 Nephrectomy Rats

Localized Camp-Dependent Signaling Mediates Beta 2-Adrenergic Modulation of Cardiac Excitation-Contraction Coupling.

Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts

8-Isoprostaglandin E2 Activates Ca2+-Dependent K+ Current Via Cyclic Amp Signaling Pathway in Murine Renal Artery

Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes

The Effects of 17Β-Estradiol and Progesterone on Cardiomyocyte Hypertrophy Induced by Endothelin-1

Beta 1-Adrenoceptor Stimulation and Beta 2-Adrenoceptor Stimulation Differ in Their Effects on Contraction, Cytosolic Ca2+, and Ca2+ Current in Single Rat Ventricular Cells.

Activation of G Protein-Coupled Estrogen Receptor (GPER) Negatively Modulates Cardiac Excitation–Contraction Coupling (ECC) through the PI3K/NOS/NO Pathway

Constitutive Beta(2)-Adrenergic Signalling Enhances Sarcoplasmic Reticulum Ca2+ Cycling to Augment Contraction in Mouse Heart

Prostaglandin E1 attenuates post‐cardiac arrest myocardial dysfunction through inhibition of mitochondria‐mediated cardiomyocyte apoptosis

Pepducin ICL1-9-Mediated β2-Adrenergic Receptor-Dependent Cardiomyocyte Contractility Occurs in a Gi Protein/ROCK/PKD-Sensitive Manner